Airline Industry Today
SEE OTHER BRANDS

Fresh airlines and aviation news from the world

Airline Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Industry Today.

Press releases published on April 23, 2025

First Watch Announces Flagship Location in Heart of Downtown Boston

First Watch Announces Flagship Location in Heart of Downtown Boston

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading daytime restaurant serving breakfast, brunch and lunch, announced it will open its first downtown Boston location in …

Churchill Downs Incorporated Announces Updates on Capital Projects for Churchill Downs Racetrack

Churchill Downs Incorporated Announces Updates on Capital Projects for Churchill Downs Racetrack

LOUISVILLE, Ky., April 23, 2025 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) (Nasdaq: CHDN) announced today renovations of the existing Finish Line Suites and The Mansion at Churchill Downs Racetrack with expected completion in …

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

 ACV to Report First Quarter 2025 Financial Results on May 7, 2025

ACV to Report First Quarter 2025 Financial Results on May 7, 2025

BUFFALO, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- ACV (NYSE: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that the Company will report first quarter 2025 financial results …

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units

ATHENS, Greece, April 23, 2025 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of LNG carriers, today announced that its Board of Directors has declared a cash distribution of $0.5625 per unit on its …

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the United States Patent and …

TFI International Announces 2025 First Quarter Results

TFI International Announces 2025 First Quarter Results

First quarter operating income of $114.6 million compares to $151.6 million in the same prior year quarter First quarter net income of $56.0 million compares to $92.8 million in Q1 2024, while adjusted net income1 of $64.2 million compares to $105.5 …

TFI International communique ses résultats du premier trimestre 2025

TFI International communique ses résultats du premier trimestre 2025

Le bénéfice opérationnel du premier trimestre de 114,6 M$ se compare à celui de 151,6 M$ au trimestre correspondant de l’exercice précédent. Le bénéfice net du premier trimestre de 56,0 M$ se compare à celui du premier trimestre de 2024 de 92,8 M$, tandis …

RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025

RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025

ALISO VIEJO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the …

Beyond Meat® to Report First Quarter 2025 Financial Results on May 7, 2025

Beyond Meat® to Report First Quarter 2025 Financial Results on May 7, 2025

EL SEGUNDO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the first quarter ended March 29, 2025 on Wednesday …

Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event

Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event

Company outlined potential for value creation driven by obe-cel across multiple B cell driven malignancies and autoimmune diseases, including acute lymphoblastic leukemia (ALL), lupus nephritis (LN) and multiple sclerosis (MS) Preliminary data in initial …

Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA

Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA

RENO, Nev., April 23, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced preliminary first quarter 2025 Net Sales and …

OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025

OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025

WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to …

Covenant Logistics Group Announces First Quarter 2025 Financial and Operating Results

Covenant Logistics Group Announces First Quarter 2025 Financial and Operating Results

CHATTANOOGA, Tenn., April 23, 2025 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (NYSE: CVLG) (“Covenant” or the “Company”) announced today financial and operating results for the first quarter ended March 31, 2025. The Company’s conference call to …

Jewett-Cameron Expands Operational Efficiency Efforts

Jewett-Cameron Expands Operational Efficiency Efforts

NORTH PLAINS, Ore., April 23, 2025 (GLOBE NEWSWIRE) -- Jewett-Cameron Trading Company Ltd. (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, today announced continued progress in its operational efficiency efforts …

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Reliance, Inc. Reports First Quarter 2025 Financial Results

Reliance, Inc. Reports First Quarter 2025 Financial Results

-- Net sales of $3.48 billion with record tons sold, up 9.0% year-over-year (same-store tons sold up 5.6%)  -- Strong gross profit margin of 29.7%  -- EPS of $3.74; non-GAAP EPS of $3.77  -- Repurchased $253.2 million of common stock SCOTTSDALE, Ariz., …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service